Proposed approval of the new active constituent, cefquinome sulphate, and registration of Cobactan IV

This consultation closed on 7 April 2015

Consultation period

10 March 2015 to 7 April 2015

The APVMA is considering an application for the registration of the product Cobactan IV. The product is to be used for the treatment of bacterial respiratory infections in adult horses.

We invite comment from 10 March 2015 to 7 April 2015 on whether the application for approval of the active constituent and registration of the product should be granted.

For more information, APVMA Gazette Notice (page 29) from 10 March 2015.

Please send your written submission by email, post or fax to:

Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

Fax: +61 2 6210 4741

For enquiries, please call +61 2 6210 4701. 

Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.